Search for: "United States v. AT&T, Inc." Results 8321 - 8340 of 8,840
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent… [read post]
7 May 2008, 7:11 am
  Conference of May 22, 2008 __________________ Docket: 07-976 Case name: T-Mobile USA, Inc., et al. v. [read post]
6 May 2008, 5:04 am
Asset Marketing Inc., No. 05-CV-00633 (S.D.Cal.), filed in March 2005, in the United States District Court for the Southern District of California, and certified as a state-wide class action (covering a class that “partially overlaps the Negrete class”) in July 2006; Mooney v. [read post]
2 May 2008, 7:00 am
: (Class 46), ICANN on cost to end domain tasting: (Class 46), ICANN can’t – but can you? [read post]
2 May 2008, 1:03 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKCriminal Practice Prison Term Is Reduced Due to Retroactive Application of Guideline Amendments United States v. [read post]
28 Apr 2008, 12:00 pm
Lee, a director since 1994, is also a director of United States Steel Corporation, Marathon Oil Corporation, The Procter & Gamble Company and The DIRECTV Group, Inc. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
25 Apr 2008, 10:00 am
Wilson developed pulmonary fibrosis and sued the chemical manufacturers, suppliers and air conditioning unit manufacturers including the defendant, American Standard, Inc. [8] His contention was that the companies failed to adequately warn him of the dangers of being exposed to R-22. [9] The defendant moved for summary judgment claiming that it had no duty to warn to Mr. [read post]